Total Payments
$1,687
2024 Payments
$306.83
Companies
15
Transactions
99
Medicare Patients
775
Medicare Billing
$125,857
Payment Breakdown by Category
Food & Beverage$1,247 (74.0%)
Education$439.16 (26.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,247 | 93 | 74.0% |
| Education | $439.16 | 6 | 26.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $668.20 | 32 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $173.20 | 10 | $0 (2024) |
| ABBVIE INC. | $171.02 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $139.86 | 9 | $0 (2023) |
| ITI, Inc. | $114.80 | 6 | $0 (2023) |
| Alkermes, Inc. | $104.17 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $94.33 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $68.04 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $31.47 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $27.75 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $306.83 | 15 | Teva Pharmaceuticals USA, Inc. ($155.05) |
| 2023 | $466.30 | 37 | Teva Pharmaceuticals USA, Inc. ($210.08) |
| 2022 | $514.75 | 29 | Teva Pharmaceuticals USA, Inc. ($303.07) |
| 2021 | $304.41 | 17 | Neurocrine Biosciences, Inc. ($142.73) |
| 2017 | $94.33 | 1 | Sunovion Pharmaceuticals Inc. ($94.33) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $40.77 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Central Nervous System | ||||||
| 07/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Central Nervous System | ||||||
| 06/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Neuropsychiatry | ||||||
| 05/10/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $79.50 | General |
| 05/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Neuropsychiatry | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Neurology | ||||||
| 04/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Central Nervous System | ||||||
| 03/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Central Nervous System | ||||||
| 03/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Neurology | ||||||
| 03/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: CNS | ||||||
| 03/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Central Nervous System | ||||||
| 12/12/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Neurology | ||||||
| 10/13/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Neurology | ||||||
| 10/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 190 | 375 | $67,536 | $26,272 |
| 2022 | 6 | 312 | 642 | $104,481 | $50,143 |
| 2021 | 6 | 232 | 527 | $88,690 | $43,197 |
| 2020 | 2 | 41 | 63 | $9,848 | $6,245 |
Total Patients
775
Total Services
1,607
Medicare Billing
$125,857
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 166 | $43,766 | $12,570 | 28.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 80 | 133 | $10,324 | $7,521 | 72.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 31 | $5,498 | $3,591 | 65.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 45 | $7,949 | $2,590 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 236 | $56,621 | $19,432 | 34.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 124 | 182 | $18,329 | $14,030 | 76.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 43 | $8,245 | $6,456 | 78.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 89 | $14,237 | $4,732 | 33.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 75 | $5,306 | $4,097 | 77.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 17 | 17 | $1,742 | $1,395 | 80.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 233 | $49,975 | $21,395 | 42.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 59 | 137 | $13,712 | $10,883 | 79.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 71 | $10,539 | $4,461 | 42.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 36 | 36 | $9,368 | $2,381 | 25.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 37 | $2,575 | $2,060 | 80.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $2,521 | $2,017 | 80.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 26 | 26 | $6,032 | $3,141 | 52.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 37 | $3,816 | $3,104 | 81.3% |
About Dr. Xiaofan Li, MD
Dr. Xiaofan Li, MD is a Psychiatry healthcare provider based in Sioux Falls, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1962631085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Xiaofan Li, MD has received a total of $1,687 in payments from pharmaceutical and medical device companies, with $306.83 received in 2024. These payments were reported across 99 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,247).
As a Medicare-enrolled provider, Li has provided services to 775 Medicare beneficiaries, totaling 1,607 services with total Medicare billing of $125,857. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Student in an Organized Health Care Education/Training Program
- Location Sioux Falls, SD
- Active Since 07/10/2009
- Last Updated 03/04/2016
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1962631085
Products in Payments
- VRAYLAR (Drug) $171.02
- INGREZZA (Drug) $165.73
- AUSTEDO (Drug) $160.70
- CAPLYTA (Drug) $114.80
- INVEGA SUSTENNA (Drug) $105.46
- LATUDA (Drug) $94.33
- Austedo XR (Drug) $93.02
- ARISTADA (Drug) $70.46
- COBENFY (Drug) $68.04
- UZEDY (Drug) $49.50
- INVEGA TRINZA (Drug) $34.40
- LYBALVI (Drug) $33.71
- ABILIFY MAINTENA (Drug) $31.47
- BELSOMRA (Drug) $27.75
- HETLIOZ (Drug) $25.61
- REXULTI (Drug) $15.37
- NUEDEXTA (Drug) $14.87
- Auvelity (Drug) $13.18
- QUVIVIQ (Drug) $12.84
- Nuedexta (Drug) $11.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Sioux Falls
James Chiu, M.d, M.D
Psychiatry — Payments: $1.2M
Psychiatry $1.2M
Hari Kannan, M.d, M.D
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Rajesh Singh, Md, MD
Psychiatry — Payments: $432,158
Psychiatry $432,158
Anthony Vaca, M.d, M.D
Psychiatry — Payments: $29,351
Psychiatry $29,351
David Ermer, Md, MD
Psychiatry — Payments: $4,646
Psychiatry $4,646
Mackenzie Mertz, Do, DO
Psychiatry — Payments: $4,595
Psychiatry $4,595